Clinical Trial Update: Efficacy of Metformin Versus Sitagliptin on Benign Thyroid Nodules in Type 2 Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing metformin to sitagliptin for efficacy in patients with type 2 diabetes and benign thyroid nodules; current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Nodule
• Type 2 Diabetes Mellitus

Drugs mentioned

• Sitagliptin (sitagliptin)
• metformin (metformin)

Snippet

Sponsor: Centre Hospitalier Universitaire de la Guadeloupe | Conditions: Diabetes Mellitus, Type 2, Thyroid Nodule (Benign) | Phase 4 | Status: UNKNOWN